NOVAVAX, INC revenue breakdown overview

NOVAVAX, INC revenue for the last year amounted to 14.22 B MXN, the most of which — 3.97 B MXN — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 9.03 B MXN. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX, INC 1.94 B MXN, and the year before that — 4.56 B MXN.